COVID-19 pandemic threatens global life-saving gains in childhood cancer
Prof Kathy Pritchard-Jones - University College London, London, UK
12 Feb 2021
Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukae...
Dr Erica Brivio - Princess Máxima Center for Pediatric Oncology, Utrecht, Nether...
9 Dec 2020
Neurocognitive impairment in long-term survivors of childhood Hodgkin lymphoma
Dr Annalynn M Williams - St. Jude Children's Research Hospital, Memphis, USA
7 Dec 2020
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Trea...
Dr Janine Stutterheim - Princess Máxima Center, Utrecht, Netherlands
7 Dec 2020
Prospective validation of single mouse testing by the paediatric preclinical tes...
Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA
4 Nov 2020
Total body radiation vs chemotherapy-based conditioning in children and adolesce...
Prof Christina Peters - Children's Cancer Research Institute, Vienna, Austria
9 Sep 2020
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
3 Jul 2020
The paediatric precision oncology study INFORM: Clinical outcome and benefit for...
Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, ...
30 May 2020
COVID-19: Managing paediatric patients under the COVID pandemic
Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami
4 May 2020
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
Prof Marc Peeters and Prof Jesus Garcia-Foncillas
9 Mar 2020
Indian Pediatric Oncology Group (InPOG)
Dr. Ramandeep Arora - Max Institute of Cancer Care, Saket, New Delhi, India
20 Feb 2020
Outcomes in paediatric oncology: Are we closing the gap between LMICs and high-i...
Prof Laila Hessissen - Mohammed V University of Rabat, Rabat, Morocco
7 Feb 2020
